SAN DIEGO (Dec. 17, 2020) Cherie Hohn, a phlebotomist assistant assigned to Naval Medical Center San Diego’s Naval Branch Health Clinic Kearny Mesa, draws a patient’s blood for a preliminary baseline antibody test for the Phase III trial of AstraZeneca’s COVID-19 vaccine candidate, Dec. 17, 2020. The trial is part of Operation Warp Speed, a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. Naval Medical Center San Diego’s mission is to prepare service members to deploy in support of operational forces, deliver high quality healthcare services and shape the future of military medicine through education, training and research. Naval Medical Center San Diego employs more than 6,000 active duty military personnel, civilians, and contractors in Southern California to provide patients with world-class care anytime, anywhere. (U.S. Navy photo by Mass Communication Specialist 3rd Class Jake Greenberg)